News & Events
Center News
The Phelan-McDermid Syndrome Drug Development Symposium (PMSDDS)
We are pleased to invite you to the Phelan-McDermid Syndrome Drug Development Symposium on April 25-26!
The Phelan-McDermid Syndrome Drug Development Symposium (PMSDDS) is the first meeting of its kind, bringing together biopharmaceutical companies with SHANK3 basic scientists, PMS clinical experts, and regulatory experts. Through this symposium, CureSHANK aims to foster thoughtful discussion, shape the future of PMS clinical trials, and accelerate drug development.
See confirmed speakers at this link, and the full agenda on the registration site.
AGENDA IN BRIEF
Thursday, April 25:
Welcome Reception/Poster Session with drinks & appetizers
Friday, April 26
Full day of talks addressing the most critical questions in drug development for Phelan-McDermid syndrome. Breakfast and lunch included; concludes at 4pm.
IMPORTANT INFORMATION
- REGISTRATION for PMSDDS is FREE
- Attendees are responsible for their own travel arrangements
- Group rate hotel rooms now available through April 11
- POSTER SESSION: Young investigators interested in participating in the poster session (which will be ePosters) should designate this when prompted during the registration process.
- *If your poster is selected for inclusion, CureSHANK will provide a travel stipend.*
Please direct any questions not answered by the registration site to connect@cureshank.org.
We hope to see you on April 25th!
